Write a bill that profits drug companies and hospitals, while making the entire health-sector more dependent on government — then go to work as a lobbyist or “policy advisor” for those very companies.
That’s what Democratic staffers did and are doing with regard to health-care reform. I call it “The Great Health-Care Cashout,” and we’ve been tracking it here.
The latest public servants to parlay “reform” to riches are Connie Garner and Stacy Sachs, both of whom are joining Foley Hoag, a lobbying firm that represents the leading drug companies (which were the biggest winners from “reform.”)
Garner, a policy director at the Senate Health, Education, Labor & Pensions (HELP) Committee, was a chief of author of the portion of “reform” known as the CLASS Act, which provides government insurance for long-term care. This measure kills the private long-term-care insurance market, but it subsidizes long-term care businesses, which, of course, supported the measure.
Foley Hoag says Garner will “will focus her practice on representation of national health trade organizations, health providers, national disability, patient advocacy organizations, and educational institutions.” It sounds like she may not register as a lobbyist, but will instead by a Tom Daschle-like non-lobbyist lobbyist.
Sachs had been at HELP since 1998. Foley Hoag writes, “In her role as Committee Counsel Ms. Sachs has been involved in all of the major Medicare and Medicaid policies over the past decade including the Medicare Modernization Act of 2003 and the recently enacted Patient Protection and Affordable Care Act of 2010. ”
Foley Hoag lobbyist Thomas barker explicitly says companies will be paying her to figure out how to deal with the bill she helped write: “She is widely respected on and off the Hill and in the Administration, and will play a critical role in advising providers and health care organizations on the implementation of the newly enacted health care reform law, the Affordable Care Act.”
Foley Hoag’s clients include Abbott Laboratories, Amgen, Astra-Zeneca, Biotechnology Industry Organization, Bristol-Myers-Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, and PhRMA.
Imagine if Garner and Sachs had written bills reforming health-care by getting government out of the industry. You can imagine their lobbying and consulting services would not be in such demand.
Again, check out our chart of other “reform” authors to see who has already cashed out and who hasn’t yet.